Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Induced pluripotent stem cells as a tool for gaining new insights into Fanconi anemia.

Cell cycle (Georgetown, Tex.) - 15 Aug 2012

Müller Lars U W, Schlaeger Thorsten M, DeVine Alexander L, Williams David A

Abstract excerpt

Induced pluripotent stem cells (iPSC) hold significant promise for advancing biomedical research. In the case of monogenic diseases, patient-iPSC and their derivatives contain the disease-causing mutation, suggesting the possibility of recapitulating salient disease features in vitro. Fanconi anemia (FA) is the most common inherited bone marrow failure syndrome. The etiology of bone marrow failure in FA remains...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cellular Reprogramming
Share to Chromosomes, Human

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Embryoid Bodies

Share to Fanconi Anemia

Share to Hematopoiesis

Share to Metaphase

Share to Mice, SCID

Share to Xenograft Model Antitumor Assays

Source

Open in PubMed Open full text

Identifiers

PMID: 22825249
DOI: 10.4161/cc.21109
PMCID: PMC3442908

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Induced pluripotent stem cells as a tool for gaining new insights into Fanconi anemia.PMID 22825249Read ↗

Modeling blood diseases with human induced pluripotent stem cellsSemantic proximity Read ↗

Hematopoietic defects and iPSC disease modeling: lessons learned.Semantic proximity Read ↗

Modeling primitive and definitive erythropoiesis with induced pluripotent stem cellsSemantic proximity Read ↗

Human-induced pluripotent stem cells from blood cells of healthy donors and patients with acquired blood disorders.Semantic proximity Read ↗

Application of iPS cells derived from congenital myelodysplastic syndrome for research of nomal hematopoesis and hematological malignancies.Semantic proximity Read ↗

Induced Pluripotent Stem Cells as a Tool for Modeling Hematologic Disorders and as a Potential Source for Cell-Based TherapiesSemantic proximity Read ↗

Recent Updates on Induced Pluripotent Stem Cells in Hematological DisordersSemantic proximity Read ↗

Disrupted Signaling through the Fanconi Anemia Pathway Leads to Dysfunctional Hematopoietic Stem Cell Biology: Underlying Mechanisms and Potential Therapeutic StrategiesSemantic proximity Read ↗

Patient-Specific Induced Pluripotent Stem Cells for Disease Modeling and Phenotypic Drug Discovery.Semantic proximity Read ↗

Blood Derived Induced Pluripotent Stem Cells (iPSCs): Benefits, Challenges and the Road AheadSemantic proximity Read ↗

iPSC modeling of severe aplastic anemia reveals impaired differentiation and telomere shortening in blood progenitorsSemantic proximity Read ↗

Patient-Derived iPSCs Faithfully Represent the Genetic Diversity and Cellular Architecture of Human Acute Myeloid LeukemiaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.